Clinical Trial Update: A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the safety of a dry-powder measles vaccine delivered by two devices; study completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles

Drugs mentioned

• Measles vaccine (dry powder)

Snippet

Sponsor: Serum Institute of India Pvt. Ltd. | Conditions: Prophylaxis for the Measles Infection | Phase 1 | Status: COMPLETED | Results posted: 2014-12-01